Shares Magazine
6.75p+0.00 (+0.00%)08 Dec 2025, 16:37
Jump to:
Renalytix PLC Fundamentals
| Company Name | Renalytix PLC | Last Updated | 2025-12-08 |
|---|---|---|---|
| Industry | Health Information Services | Sector | Healthcare |
| Shares in Issue | 437.019 m | Market Cap | £29.50 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -$0.07 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.7172 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | -8.3572 | Cash Equity Ratio | -7.0314 |
| Quick Ratio | 2.2011 | Current Ratio | 2.43 |
| Price To Book Value | 0 | ROCE | 0 |
Renalytix PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Renalytix PLC Company Financials
| Assets | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible Assets | $200,000.00 | $200,000.00 | $1.19 m | $1.37 m |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | $1.46 m | $2.75 m |
| Total Fixed Assets | $300,000.00 | $300,000.00 | $3.75 m | $5.31 m |
| Stocks | $200,000.00 | $300,000.00 | 0 | 0 |
| Debtors | $600,000.00 | $700,000.00 | $776,000.00 | $976,000.00 |
| Cash & Equivalents | $3.70 m | $5.40 m | $24.68 m | $41.33 m |
| Other Assets | $100,000.00 | $100,000.00 | 0 | 0 |
| Total Assets | $6.10 m | $7.10 m | $30.63 m | $50.06 m |
| Liabilities | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Creditors within 1 year | $4.80 m | $11.80 m | $16.14 m | $11.78 m |
| Creditors after 1 year | $8.30 m | $4.30 m | $7.53 m | $7.68 m |
| Other Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | $13.10 m | $16.10 m | $23.66 m | $19.46 m |
| Net assets | -$7.00 m | -$9.00 m | $6.97 m | $30.61 m |
| Equity | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Called up share capital | $1.10 m | $500,000.00 | $286,000.00 | $228,000.00 |
| Share Premium | $141.30 m | $121.80 m | $186.46 m | $164.01 m |
| Profit / Loss | -$21.80 m | -$45.50 m | -$45.60 m | -$45.25 m |
| Other Equity | -$7.00 m | -$9.00 m | $6.97 m | $30.61 m |
| Preference & Minorities | 0 | 0 | 0 | 0 |
| Total Capital Employed | -$7.00 m | -$9.00 m | 0 | $30.61 m |
| Ratios | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Debt Ratio | 0 | 0 | $0.52 | $0.20 |
| Debt-to-Equity | 0 | 0 | $1.08 | $0.25 |
| Assets / Equity | -8.3572 | -8.3572 | -8.3572 | -8.3572 |
| Cash / Equity | -7.0314 | -7.0314 | -7.0314 | -7.0314 |
| EPS | -$0.05 | -$0.28 | -$0.50 | -$0.60 |
| Cash Flow | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash from operating activities | -$17.90 m | -$29.80 m | -$34.09 m | -$45.92 m |
| Cashflow before financing | -$1.90 m | -$19.80 m | -$17.70 m | -$20.29 m |
| Increase in Cash | -$1.90 m | -$19.70 m | -$16.65 m | -$23.80 m |
| Income | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Turnover | $3.00 m | $2.30 m | $3.40 m | $2.97 m |
| Cost of sales | $1.80 m | $2.10 m | $2.68 m | $2.10 m |
| Gross Profit | $1.20 m | $200,000.00 | $720,000.00 | $874,000.00 |
| Operating Profit | -$17.20 m | -$30.50 m | -$42.22 m | -$53.18 m |
| Pre-Tax profit | -$21.80 m | -$45.50 m | -$45.60 m | -$45.25 m |
Renalytix PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease. Its product, KidneyIntelX, is designed to improve kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. The Company's service, KidneyIntelX.dkd, enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX uses a proprietary algorithm combining blood-based biomarkers, inherited genetics, and electronic health record data to generate a patient risk score predicting rapid kidney function decline. |
| Latest Interim Date | 18 Mar 2025 |
| Latest Fiscal Year End Date | 3 Nov 2025 |
Renalytix PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2022-04-07 | Ms. Ann E. Berman | Independent Director |
| 2023-11-22 | Mr. Howard B. Doran, Jr. | Chief Business Officer |
| 2024-06-13 | Mr. Joel R. Jung | Interim Chief Financial Office |
| 2023-07-11 | Mr. Thomas H. Mclain | President |
| 2023-10-24 | Mr. Timothy John Scannell | Non-Executive Director |
| 2024-10-31 | Mr. Daniel Joseph Levangie | Non-Executive Director |
| 2025-11-04 | Mr. Christopher Harwood Bernard Mills | Non-Executive Director |
| 2025-11-04 | Mr. Julian Huw Baines MBE | Executive Director,Chairman |
| 2020-07-17 | Mr. Richard Anthony Evans | Non-Executive Director |
| 2025-11-04 | Mr. James Renwick McCullough | Executive Director,Chief Executive Officer |
| 2025-11-04 | Mr. Fergus Fleming | Executive Director,Chief Technical Officer |
| 2021-07-01 | Dr. Barbara Murphy | Non-Executive Director |
| 2023-07-03 | Dr. Erik Lium | Director |
| 2024-12-03 | Mr. O. James Sterling | Chief Financial Officer and Principal Accounting Officer |
| 2023-12-08 | Dr. Chirag Rohit Parikh | Non-Executive Director |
| 2023-07-07 | Dr. Michael J. Donovan, M.D.,PhD | Chief Medical Officer |
| 2025-11-04 | Ms. Catherine Havlik Coste | Non-Executive Director |
| 2025-11-04 | Mr. Robert Graham Naylor | Non-Executive Director |
Renalytix PLC Contact Details
| Company Name | Renalytix PLC |
|---|---|
| Address | 19 Stanwell Road, Avon House, Cardiff, CF64 2EZ |
| Telephone | |
| Website | https://www.renalytix.com |
Renalytix PLC Advisors
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Kainos Group PLC | 1,155.00 | 6.65 |
| Paypoint PLC | 461.00 | 5.13 |
| Oxford Nanopore Technologies PLC | 130.50 | 4.65 |
| Baltic Classifieds Group PLC | 183.40 | 4.56 |
| Trustpilot Group PLC | 152.40 | 4.10 |
| Oxford Biomedica PLC | 644.00 | 4.04 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Sdcl Efficiency Income Trust PLC | 52.70 | -16.22 |
| Future PLC | 585.50 | -7.65 |
| Vistry Group PLC | 614.00 | -4.18 |
| Barratt Redrow PLC | 363.20 | -3.97 |
| Unite Group PLC | 510.00 | -3.77 |
| Jd Sports Fashion PLC | 79.60 | -3.77 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.